New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareNoopept vs Dulaglutide

Noopept vs Dulaglutide

Side-by-side comparison of key properties, dosing, and research.

Cognitive Enhancement
Noopept
GLP-1 / Weight Loss Agonists
Dulaglutide
Summary
Noopept is a potent dipeptide-derived nootropic from Russia, structurally related to piracetam but estimated to be 1,000 times more potent by mass. It enhances memory consolidation, learning, and recall while providing neuroprotection via BDNF and NGF upregulation.
Dulaglutide (brand name Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for type 2 diabetes management and cardiovascular risk reduction. It consists of two GLP-1 analog chains fused to a modified IgG4 Fc fragment, extending its half-life to approximately 5 days. While primarily a diabetes medication, it produces meaningful weight loss and has established cardiovascular outcomes data from the REWIND trial.
Half-Life
~5–10 minutes but metabolite (CPG) effects last hours
~5 days
Admin Route
Oral, Sublingual, Intranasal
SubQ
Research
Typical Dose
10–30 mg
0.75 mg → 1.5 mg
Frequency
1–2x daily
Once weekly
Key Benefits
  • Enhances memory formation and recall
  • Improves learning speed and cognitive processing
  • Neuroprotective via BDNF/NGF upregulation
  • Anxiolytic at low-to-moderate doses
  • Improves verbal fluency and information processing
  • Antioxidant (reduces oxidative damage in neurons)
  • May improve cognitive symptoms of mild cognitive impairment
  • FDA-approved for type 2 diabetes
  • Once-weekly subcutaneous dosing via auto-injector pen
  • Reduces HbA1c by approximately 1.1–1.6%
  • Modest weight loss of 1.5–3 kg at approved doses
  • Demonstrated cardiovascular risk reduction (REWIND trial)
  • Established long-term safety profile
  • Renal protective effects in CKD
Side Effects
  • Headaches (choline depletion — pair with choline source)
  • Irritability or anxiety at high doses
  • Overstimulation
  • Rare: brain fog with chronic use
  • +1 more
  • Nausea (most common, typically transient)
  • Diarrhea
  • Vomiting
  • Decreased appetite
  • +3 more
Stacks With